Actinium Pharmaceuticals, Inc. ( ATNM) - Stock Earnings
ATNM Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 13, 2026, midnight | — / — | — | — / — | — |
ATNM Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -5.9 million USD | — USD |
| 2026Q1 | -5.5 million USD | — USD |
| 2026Q2 | 27.9 million USD | 35.0 million USD |
| 2026Q4 Est. | — | — |
ATNM Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -48.8 million USD | 81000 USD |
| 2024 | -38.2 million USD | — USD |
| 2025 | -33.9 million USD | 90000 USD |
| 2026 Est. | — | — |
ATNM
Price: $1.13
52 week price:
Earnings Per Share: -0.76 USD
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 219900
Market Capitalization: 37.6 million